F.D.A. Rejects Closely Watched Lung Cancer Drug From China

New York Times - Nov 15, 2026

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

Read full article

More News


The Budget Report

Delivers the latest news of various finance and economic status in the ever-changing world economy to make sure everyone is up-to-date with the current trends.